Author

Manuel L Neves

AB Science (France)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Abdellah Benjahad· 1 shared Alain Moussy· 1 shared Armelle GoubardiD· 1 shared Benoı̂t GigantiD· 1 shared Bérengère Hajem· 1 shared Camille MontersinoiD· 1 shared Christian Auclair· 1 shared Colin D. MansfieldiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Abdellah Benjahad

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identification of AB8939, a novel synthetic microtubule destabilizer and ALDH inhibitor that overcomes multidrug resistance in tumor cells as a drug candidate for the treatment of refractory acute myeloid leukemia

Martine Humbert, Sébastien Letard, Armelle Goubard, Camille Montersino, Stéphane Audebert, Émilie Baudelet, Bérengère Hajem, Manuel L Neves, Samila Siavioshian, Paloma F. Varela, Benoı̂t Gigant, E. Rebuffet, Pascal Verdier‐Pinard, Rémy Castellano, Yves Collette, , Patrice C. Dubreuil

This paper identifies AB8939, a novel drug that targets microtubules and ALDH enzymes, showing efficacy against drug-resistant AML cells and models.

bioRxiv · Dec 12, 2025 · PreprintCell Biology